Posted on 18/05/2020
In order to serve hospitals, surgeons and patients around the world in need of cataract surgery and ophthalmic treatment, Rayner has today opened its commercial office. This means that our customer service, technical support and logistics teams are available to serve our customers as normal. Our factory never stopped producing our award-winning intraocular lenses meaning
Posted on 14/05/2020
Worthing (UK) – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and last month revealed as a winner of the 2020 Queen’s Awards for Enterprise (Innovation) for its RayOne IOL injector system, announced today that it substantially increased IOL production levels between January and April, despite NHS elective surgery being postponed
Posted on 21/04/2020
Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in
Posted on 21/04/2020
Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in
Posted on 20/03/2020
Dear All, I want to reassure you in these uncertain times. Rayner is very fortunate to operate globally and in an industry which is critical. Despite the worsening situation in Europe and the Americas we are thankfully seeing improvements in Asia. Several large markets are operating relatively unaffected. Despite the turmoil that we see on
Posted on 11/09/2019
Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing
Posted on 1/09/2019
Rayner partners and acquires stake in Reper to drive R&D and build presence in Russia. Following a four-year R&D collaboration on a novel hydrophobic IOL material, Rayner has acquired a substantial stake in Reper, a leading material science and medical device company based in Russia. The new proprietary non-glistening material is the basis for RayOne
Posted on 11/12/2018
Rayner set to launch 600C monofocal aspheric IOL at ASCRS
Rayner has announced the launch of the 600C Aspheric IOL. The 600C Aspheric IOL will be unveiled at the upcoming 2018 ASCRS conference in Washington, DC, 13-17 A...
Posted on 4/09/2018
In response from the letter received from the RtHon Matt Hancock MP, Secretary of State for Health:
Rayner is a UK headquartered business and the only manufacturer of intraocular lenses (IOLs) in the UK, pr...
Posted on 7/08/2018
Rayner are proud to announce the launch of the new, CE marked Sulcoflex Trifocal Pseudophakic Supplementary IOL at the 2018 ESCRS in Vienna
...